Brian Birchler - Net Worth and Insider Trading
Brian Birchler Net Worth
The estimated net worth of Brian Birchler is at least $2 Million dollars as of 2025-07-04. Brian Birchler is the EVP, Corp and Development Ops of Ionis Pharmaceuticals Inc and owns about 56,660 shares of Ionis Pharmaceuticals Inc (IONS) stock worth over $2 Million. Details can be seen in Brian Birchler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian Birchler has not made any transactions after 2025-04-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brian Birchler
Brian Birchler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian Birchler owns 1 companies in total, including Ionis Pharmaceuticals Inc (IONS) .
Click here to see the complete history of Brian Birchler’s form 4 insider trades.
Insider Ownership Summary of Brian Birchler
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| IONS | Ionis Pharmaceuticals Inc | 2025-04-16 | EVP & Corp and Development Ops |
Brian Birchler Latest Holdings Summary
Brian Birchler currently owns a total of 1 stock. Brian Birchler owns 56,660 shares of Ionis Pharmaceuticals Inc (IONS) as of April 16, 2025, with a value of $2 Million.
Latest Holdings of Brian Birchler
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IONS | Ionis Pharmaceuticals Inc | 2025-04-16 | 56,660 | 43.00 | 2,436,380 |
Holding Weightings of Brian Birchler
Brian Birchler Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian Birchler has made a total of 5 transactions in Ionis Pharmaceuticals Inc (IONS) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Ionis Pharmaceuticals Inc is the sale of 680 shares on April 16, 2025, which brought Brian Birchler around $19,292.
Insider Trading History of Brian Birchler
- 1
Brian Birchler Trading Performance
Brian Birchler Ownership Network
Ownership Network List of Brian Birchler
Ownership Network Relation of Brian Birchler
Brian Birchler Owned Company Details
What does Ionis Pharmaceuticals Inc do?
Who are the key executives at Ionis Pharmaceuticals Inc?
Brian Birchler is the EVP & Corp and Development Ops of Ionis Pharmaceuticals Inc. Other key executives at Ionis Pharmaceuticals Inc include Chief Business Officer Joseph Baroldi , director & Senior Vice President Brett P Monia , and SVP & Legal and General Counsel Patrick R. O'neil .
Ionis Pharmaceuticals Inc (IONS) Insider Trades Summary
Over the past 18 months, Brian Birchler made 4 insider transaction in Ionis Pharmaceuticals Inc (IONS) with a net sale of 11,482. Other recent insider transactions involving Ionis Pharmaceuticals Inc (IONS) include a net sale of 198,346 shares made by Brett P Monia , a net sale of 34,288 shares made by Patrick R. O'neil , and a net sale of 30,715 shares made by Eric Swayze .
In summary, during the past 3 months, insiders sold 7,624 shares of Ionis Pharmaceuticals Inc (IONS) in total and bought 15,000 shares, with a net purchase of 7,376 shares. During the past 18 months, 445,942 shares of Ionis Pharmaceuticals Inc (IONS) were sold and 20,000 shares were bought by its insiders, resulting in a net sale of 425,942 shares.
Ionis Pharmaceuticals Inc (IONS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ionis Pharmaceuticals Inc Insider Transactions
Brian Birchler Mailing Address
Above is the net worth, insider trading, and ownership report for Brian Birchler. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Brian Birchler's mailing address is: Carlsbad Ca 92010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
